Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominic P Behan

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
European Journal of Pharmacology|March 25, 2008
Anti-thrombotic and vascular effects of AR246686, a novel 5-HT2A receptor antagonistJohn W Adams, Juan Ramirez, Danny Ortuno, et al.
Endocrinology|January 19, 2008
A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide releaseZhi-Liang Chu, Chris Carroll, Jean Alfonso, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 25, 2009
APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biologyJohn W Adams, Juan Ramirez, Yunqing Shi, et al.
Molecular Endocrinology (Baltimore, Md.)|November 11, 2009
N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119Zhi-Liang Chu, Chris Carroll, Ruoping Chen, et al.
Endocrinology|February 10, 2007
A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin releaseZhi-Liang Chu, Robert M Jones, Hongmei He, et al.
The Journal of Biological Chemistry|April 25, 2007
Nicotinic acid receptor agonists differentially activate downstream effectorsJeremy G Richman, Martha Kanemitsu-Parks, Ibragim Gaidarov, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2015
Discovery of a novel trans-1,4-dioxycyclohexane GPR119 agonist seriesSangdon Han, Sanju Narayanan, Sun Hee Kim, et al.
Journal of Medicinal Chemistry|July 31, 2008
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in miceGraeme Semple, Philip J Skinner, Tawfik Gharbaoui, et al.
Bioorganic & Medicinal Chemistry Letters|December 10, 2014
Discovery of 1a,2,5,5a-tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalen-4-carboxamides as potent and selective CB2 receptor agonistsSangdon Han, Lars Thoresen, Xiuwen Zhu, et al.
Journal of Medicinal Chemistry|January 11, 2017
Discovery of 2-(((1r,4r)-4-(((4-Chlorophenyl)(phenyl)carbamoyl)oxy)methyl)cyclohexyl)methoxy)acetate (Ralinepag): An Orally Active Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial HypertensionThuy-Anh Tran, Bryan Kramer, Young-Jun Shin, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
European Journal of Pharmacology|March 25, 2008
Anti-thrombotic and vascular effects of AR246686, a novel 5-HT2A receptor antagonistJohn W Adams, Juan Ramirez, Danny Ortuno, et al.
Endocrinology|January 19, 2008
A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide releaseZhi-Liang Chu, Chris Carroll, Jean Alfonso, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 25, 2009
APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biologyJohn W Adams, Juan Ramirez, Yunqing Shi, et al.
Molecular Endocrinology (Baltimore, Md.)|November 11, 2009
N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119Zhi-Liang Chu, Chris Carroll, Ruoping Chen, et al.
Endocrinology|February 10, 2007
A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin releaseZhi-Liang Chu, Robert M Jones, Hongmei He, et al.
The Journal of Biological Chemistry|April 25, 2007
Nicotinic acid receptor agonists differentially activate downstream effectorsJeremy G Richman, Martha Kanemitsu-Parks, Ibragim Gaidarov, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2015
Discovery of a novel trans-1,4-dioxycyclohexane GPR119 agonist seriesSangdon Han, Sanju Narayanan, Sun Hee Kim, et al.
Journal of Medicinal Chemistry|July 31, 2008
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in miceGraeme Semple, Philip J Skinner, Tawfik Gharbaoui, et al.
Bioorganic & Medicinal Chemistry Letters|December 10, 2014
Discovery of 1a,2,5,5a-tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalen-4-carboxamides as potent and selective CB2 receptor agonistsSangdon Han, Lars Thoresen, Xiuwen Zhu, et al.
Journal of Medicinal Chemistry|January 11, 2017
Discovery of 2-(((1r,4r)-4-(((4-Chlorophenyl)(phenyl)carbamoyl)oxy)methyl)cyclohexyl)methoxy)acetate (Ralinepag): An Orally Active Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial HypertensionThuy-Anh Tran, Bryan Kramer, Young-Jun Shin, et al.
Pageof 3